To help community members understand the value and impact of research at Mayo Clinic Comprehensive Cancer Center, our researchers and Community Scientists team up to share updates in clear, everyday language. Click the links below to read the latest community updates from Mayo Clinic's six research programs:
- Advanced Clinical Trial and Translational Sciences (ACTS) - This research helps turn new scientific discoveries into real treatments. This work leads to better ways to diagnose, treat, and monitor cancer, and supports clinical trials focused on specific diseases.
- Cancer Prevention, Control, and Survivorship (CPCS) - This research helps prevent cancer, reduce its impact, and improve health for people. It also works to make treatments more effective and help patients feel better and function well during and after cancer care.
- Cancer Cell Genomics, Signaling and Metastasis (CGSM) -This research drives new scientific discoveries and helps turn them into cancer-focused tools and treatment.
- Cancer Immunology & Immunotherapy (CII) - This research focuses on understanding how the immune system works, how inflammation is linked to cancer, and how to use the body’s own defenses to fight cancer.
- Novel Therapeutics and Therapeutic Modalities (NTTM) - This research helps create cancer treatments that are more effective and have fewer side effects.
- Risk Assessment, Early Detection and Interception (REDI) - This research helps speed up the development of tools that can find cancer early and prevent it. It also focuses on using data to create targeted strategies for spotting and stopping cancer before it becomes serious.
Advanced Clinical Trial and Translational Sciences (ACTS)
2025
Cancer Prevention, Control, and Survivorship (CPCS)
2025
Cancer Cell Genomics, Signaling and Metastasis (CGSM)
2025
Cancer Immunology & Immunotherapy (CII)
2025
Novel Therapeutics and Therapeutic Modalities (NTTM)
2025
Risk Assessment, Early Detection and Interception (REDI)
2025
-
Advancing Early Detection of Pancreatic Cancer With The Power of AI
-
Understanding Breast Cancer Risk With New Insights From Genetics